Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac...

Area of Science:

• Cardiology
• Cardiac Surgery
• Pathology

Background:

• Left ventricular assist device (LVAD) therapy is crucial for end-stage heart failure.
• Assessing the potential for sustained recovery after LVAD support is essential for patient management.
• Cardiac fibrosis and myocyte size are key indicators of myocardial health.

Purpose of the Study:

• To determine if cardiac fibrosis and myocyte size at LVAD implantation predict functional recovery after device explantation.
• To evaluate the correlation between pre-implantation myocardial characteristics and post-explantation cardiac function.

Main Methods:

• Analysis of 34 patients undergoing LVAD-off tests.
• Measurement of LV end-diastolic diameter (LVEDD), LV end-systolic diameter (LVESD), LV ejection fraction (LVEF), mean pulmonary artery pressure (mPAP), pulmonary capillary wedge pressure (PCWP), and cardiac index (CI).
• Histological assessment of myocardial tissue for fibrosis and myocyte size at LVAD implantation.

Main Results:

• Significant correlations were found between cardiac fibrosis and changes in LVEDD, LVESD, LVEF, mPAP, PCWP, and CI.
• Myocyte size correlated significantly with changes in LVEDD, LVESD, and LVEF.
• Patients successfully explanted (n=9) had significantly less cardiac fibrosis and smaller myocyte size compared to those not explanted.

Conclusions:

• Pre-implantation cardiac fibrosis and myocyte size are significant predictors of improved cardiac function post-LVAD.
• These myocardial characteristics also predict sustained recovery after LVAD explantation.
• This study highlights the importance of myocardial tissue analysis for predicting LVAD outcomes.